100
Acrivon Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
132
FY23:
130
FY24:
182
FY25:
120
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.18
FY22:
49.1
FY23:
8.57
FY24:
15.0
FY25:
9.27
Total assets
Change from FY21 to FY25
millions USD
FY21:
107
FY22:
181
FY23:
138
FY24:
197
FY25:
130
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.91
FY22:
6.52
FY23:
13.3
FY24:
17.2
FY25:
15.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.96
FY22:
4.24
FY23:
3.77
FY24:
2.59
FY25:
1.54
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.8
FY22:
170
FY23:
121
FY24:
177
FY25:
113
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
181
FY23:
138
FY24:
197
FY25:
130
All amounts in millions USD